Tweenvest Stocks

Regen BioPharma, Inc. (OTCPK: RGBP)

Health Care · Biotechnology · US

$0.00

-50.00% today · -99.3% 1Y

Regen BioPharma, Inc. (OTCPK: RGBP) operates in the Biotechnology industry within the Health Care sector. The company is valued at $167.53K and employs 1 people.

Over the last twelve months the share price has lost 99.3%, trading between 0.00 and 0.02.

Tweenvest scores Regen BioPharma, Inc. across four factors: quality 20/100, value 44/100, growth 2/100. Its strongest factor is value.

RGBP price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$167.53K
Revenue (TTM)
$236.56K
P/E
—
EPS
-0.01
Dividend yield
—
Beta (5Y)
-0.33
52-week high
$0.02
52-week low
$0.00
Avg volume (3M)
—
Shares outstanding
1.68B
Employees
1
Next earnings
—

About Regen BioPharma, Inc.

Regen BioPharma, Inc. is a company dedicated to advancing regenerative medicine within the United States. It actively researches and identifies small molecule compounds designed to modulate the NR2F6 gene. This modulation is strategically aimed at activating immune cells for oncology treatments and suppressing them for autoimmune conditions. Its therapeutic pipeline and product development are currently in their initial phases. Established in 2012, the firm operates from its headquarters in La Mesa, California.

ISIN
US75886M3007
Founded
2012
Listed since
Oct 6, 2014
Exchange
Pink Sheets LLC
Currency
USD
CompanyMarket capPriceDay
Beroni Group LimitedOTCPK: BNIG.F$216.88K$——
NAVCO Pharmaceuticals Inc.TSXV: NAV$200.86KCA$0.01—
Ocean Biomedical, Inc.OTCPK: OCEA$185.89K$0.00+60.00%
Endonovo Therapeutics, Inc.OTCPK: ENDV$180.76K$0.00+100.00%
Biosergen AB (publ)OM: BIOSGN$142.46KSkr0.50+3.77%
Oxurion NVENXTBR: OXUR$126.66K€0.00-33.33%
Many Bright Ideas Technologies Inc.TSXV: MBI.H$120.88KCA$0.01—
Medigene AGHMSE: MDG1$110.54K€0.01+26.92%

Browse every Biotechnology company →

Figures last refreshed Oct 18, 2026.